Understanding the positive benefit:risk profile of alemtuzumab in relapsing multiple sclerosis: perspectives from the Alemtuzumab Clinical Development Program
Havrdova, Eva; Cohen, Jeffrey; Horáková, Dana; Kovarova, Ivana; Meluzinova, Eva
- 期刊名称Therapeutics and Clinical Risk Management
- 作者Havrdova, Eva; Cohen, Jeffrey; Horáková, Dana; Kovarova, Ivana; Meluzinova, Eva
- 电子ISSN1178-203X
- 文件大小928.69KB
- 发表时间2017-10
- DOI10.2147/TCRM.S143509
- 页码1423-1437